Regulation of ryanodine receptors by sphingosylphosphorylcholine: Involvement of both calmodulin-dependent and -independent mechanisms by Kovacs, Erika et al.
Regulation of ryanodine receptors by
sphingosylphosphorylcholine: involvement of both calmodulin-
dependent and -independent mechanisms
Erika Kovacsa, Le Xub, Daniel A. Pasekb, Karoly Lilioma, and Gerhard Meissnerb
Erika Kovacs: kovacs@enzim.hu; Le Xu: lexu@med.unc.edu; Daniel A. Pasek: pasek@email.unc.edu; Karoly Liliom:
liliom@enzim.hu; Gerhard Meissner: meissner@med.unc.edu
a Institute of Enzymology, Biological Research Center, Hungarian Academy of Sciences, Karolina
ut 29, H-1113 Budapest, Hungary
b Department of Biochemistry and Biophysics, University of North Carolina, 3010 Genetic
Medicine Bldg, 120 Mason Farm Rd, Chapel Hill, NC 27599-7260, USA
Abstract
Sphingosylphosphorylcholine (SPC), a lipid mediator with putative second messenger functions,
has been reported to regulate ryanodine receptors (RyRs), Ca2+ channels of the sarco/endoplasmic
reticulum. RyRs are also regulated by the ubiquitous Ca2+ sensor calmodulin (CaM), and we have
previously shown that SPC disrupts the complex of CaM and the peptide corresponding to the
CaM-binding domain of the skeletal muscle Ca2+ release channel (RyR1). Here we report that
SPC also displaces Ca2+-bound CaM from the intact RyR1, which we hypothesized might lead to
channel activation by relieving the negative feedback Ca2+CaM exerts on the channel. We could
not demonstrate such channel activation as we have found that SPC has a direct, CaM-independent
inhibitory effect on channel activity, confirmed by both single channel measurements and
[3H]ryanodine binding assays. In the presence of Ca2+CaM, however, the addition of SPC did not
reduce [3H]ryanodine binding, which we could explain by assuming that the direct inhibitory
action of the sphingolipid was negated by the simultaneous displacement of inhibitory Ca2+CaM.
Additional experiments revealed that RyRs are unlikely to be responsible for SPC-elicited Ca2+
release from brain microsomes, and that SPC does not exert detergent-like effects on sarcoplasmic
reticulum vesicles. We conclude that regulation of RyRs by SPC involves both CaM-dependent
and -independent mechanisms, thus, the sphingolipid might play a pysiological role in RyR
regulation, but channel activation previously attributed to SPC is unlikely.
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Sphingosylphosphorylcholine (SPC), a lipid mediator with diverse functions [1,2], displays
the unique property of being capable to mobilize Ca2+ from internal stores acting both
extracellularly through G protein-coupled receptors and intracellularly in a yet undefined
manner [3,4]. Although there is a certain level of confusion in the literature, it is important
to differentiate between these two modes of action [5]. Ghosh et al. were the first to report
on the intracellular Ca2+ release mediating ability of sphingosine derivatives [6], and since
then, two main proposals have been made on the intracellular target sites for SPC. Mao et al.
suggested the involvement of SCaMPER, a sphingolipid Ca2+ release mediating protein
from endoplasmic reticulum [7]. However, in a subsequent study Schnurbus et al.
demonstrated that SCaMPER is unlikely to be a Ca2+ channel [8]. Another suggestion was
that SPC activates ryanodine receptors (RyRs), Ca2+ channels of the endoplasmic reticulum.
These receptors were proposed to play a role in SPC-induced Ca2+ release from brain
microsomes [9] and from cardiac sarcoplasmic reticulum membranes [10]. In contrast,
Uehara et al. demonstrated that the open probability of cardiac RyR ion channels decreases
on application of SPC [11,12]; hence, the question of SPC’s intracellular mechanism of
action is still open.
RyRs are huge channel complexes composed of tetramers of 560 kDa monomers [13].
Among the three isoforms RyR1 is expressed primarily in skeletal muscle, RyR2 is the
dominant isoform in cardiac muscle, and RyR3 is found in a wide variety of tissues. They
display a characteristic bell-shaped, biphasic dependence on cytosolic Ca2+ concentration
with micromolar Ca2+ causing channel activation and elevated Ca2+ concentrations resulting
in channel inhibition. Besides Ca2+, these receptors are regulated by several small molecules
and proteins including the ubiquitous Ca2+ sensor calmodulin (CaM) [14]. Regulation of
RyRs by CaM is complex, but the sensor clearly plays a role in the negative feedback of the
Ca2+ signal, through inhibition of channel activity by Ca2+CaM [15,16].
We have previously shown that SPC can selectively bind to CaM, and inhibits its activity on
target enzymes phosphodiesterase and calcineurin [17]. Furthermore, we demonstrated that
the sphingolipid disrupts the complex between CaM and the peptide representing the CaM-
binding domain of RyR1 [18]. In this report, we describe the regulation of RyR1 by SPC
focusing on the role of CaM. We found that SPC displaces CaM from the intact RyR1, and
regulates these Ca2+ channels both in a CaM-dependent and -independent manner.
Materials and Methods
Lysophospholipids
D-erythro-sphingosylphosphorylcholine (SPC, cat. no. 860600), D-erythro-sphingosine-1-
phosphate (S1P, cat. no. 860492), oleoyl-lysophosphatidylcholine (LPC, cat. no. 845875)
and oleoyl-lysophosphatidic acid (LPA, cat. no. 857130) were purchased from Avanti Polar
Lipids. Lipids were delivered from 10 mM methanolic stock solutions.
SR vesicle preparations and RyR purification
Heavy SR vesicles were isolated from rabbit hind limb and back muscle as previously
described [19]. Endogenous CaM was removed by incubating SR vesicles for 30 min at 24
°C with 1 μM myosin light chain kinase-derived CaM binding peptide in the presence of 100
μM Ca2+ followed by centrifugation through a layer of 15% sucrose to remove complexed
CaM and the peptide [15]. For purification of RyR1, SR vesicles were solubilized in
CHAPS, purified by sucrose density gradient centrifugation, and reconstituted into
phosphatidylcholine liposomes [20].
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Single channel measurements were carried out as previously described [19] in planar lipid
bilayers containing phosphatidylethanolamine, phosphatidylserine, and phosphatidylcholine
in the ratio of 5:3:2 (25 mg of total phospholipid/ml of n-decane). The side of the bilayer to
which the proteoliposomes containing the purified RyR1s were added was defined as the cis
(cytoplasmic) side. The trans (SR lumenal) side of the bilayer was defined as ground.
Measurements were made with symmetrical 0.25 M KCl, 20 mM K-HEPES, pH 7.4, with
22 μM free Ca2+ in the cis chamber. CaM and SPC were added to the cis solution. For
+CaM samples, proteoliposomes were preincubated with 1 μM CaM at room temperature
for 30 min, and measurements were done in the presence of 100 nM cis CaM. Data were
acquired using test potentials of ±35 mV and were sampled at 10 kHz and filtered at 2 kHz.
Channel open probabilities (Po) were determined from at least 2 min of recordings for each
condition.
[3H]ryanodine binding
SR vesicles were incubated with 2.5 nM [3H]ryanodine for 20 h at room temperature in 0.3
M sucrose, 0.15 M KCl, 20 mM K-Pipes, pH 7.0, 50 times diluted protease inhibitor cocktail
(Sigma), 0.1 mg/ml BSA, either 5 mM reduced (GSH) or oxidized (GSSG) glutathione and
50 μM free Ca2+ (150 μM CaCl2, 100 μM EGTA). Nonspecific binding was determined
using heat-inactivated SR vesicles. Aliquots of the samples were diluted with 10 volumes of
ice-cold water and placed on Whatman GF/B filters soaked with 2% polyethyleneimine.
Filters were washed with three 5-ml volumes of ice-cold 0.1 M KCl, 1 mM K-Pipes, pH 7.0.
Radioactivity remaining with the filters was determined by liquid scintillation counting to
obtain bound [3H]ryanodine.
[35S]CaM binding
CaM was metabolically labeled with 35S and purified according to Balshaw et al. [15]. SR
vesicles were incubated at room temperature for 2 h with 84 nM [35S]CaM in 0.3 M sucrose,
0.15 M KCl, 20 mM K-Pipes, pH 7.0, 50 times diluted protease inhibitor cocktail (Sigma),
0.1 mg/ml BSA, 5 mM GSH and 100 μM free Ca2+ (200 μM CaCl2, 100 μM EGTA).
Equilibrium [35S]CaM binding was assayed by centrifugation in a Beckman Airfuge for 30
min at 90,000 g. Nonspecific binding was determined by measuring [35S]CaM binding to
heat-inactivated SR vesicles. Bound [35S]CaM was determined by scintillation counting
after solubilization of pellets in Tris-HCl buffer, pH 8.5, containing 2% SDS.
Membrane permeability assay
Skeletal SR vesicles were incubated for 4 h at 0 °C in a large volume (1 mg of protein/ml) of
incubation medium (0.3 M sucrose, 150 mM KCl, 20 mM K-Pipes, pH 7.0, 50 times diluted
protease inhibitor cocktail (Sigma), 0.1 mg/ml BSA, 10 mM glucose, 2 mM MgCl2),
sedimented by centrifugation for 30 min at 35,000 rpm in a Beckman 42.1 rotor, and
resuspended in a small volume (20 mg of protein/ml) of incubation medium. Vesicles were
incubated overnight at 4 °C in the presence of 0.1 mCi/ml [14C]glucose. The vesicles were
then diluted 100-fold into an unlabeled release medium supplemented with the appropriate
lysophospholipid. Efflux of [14C]glucose was terminated by placing aliquots (0.2 ml) on
0.45 μm HAWP Millipore filters followed by rapid rinsing with unlabeled release medium.
The radioactivity retained on the filters was determined by scintillation counting.
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Monomeric SPC induces long channel closings of purified RyR1 independently of CaM
The effects of SPC on the skeletal muscle ryanodine receptor (RyR1) both in the presence
and absence of CaM were studied with the method of single channel recordings in planar
lipid bilayers. Proteoliposomes containing purified RyR1 were fused with the lipid bilayer
and the resulting channel activities were recorded.
Fig. 1A shows a representative single channel recording in the absence (upper panel) and
after the addition of 1 μM SPC (lower panel) to the cis chamber with 22 μM free Ca2+ in the
cis chamber. Addition of SPC decreased single channel open probability (Po) from 0.51 to
0.16. The lipid induced long channel closings without noticeably altering the duration of
open events. In Fig. 1B, the effects of the lipid on RyR1 were measured in the presence of
100 nM CaM in the cis chamber. To assure CaM binding to RyR1, proteoliposomes were
preincubated with 1 μM CaM for 30 min. Addition of 1 μM SPC reduced Po from 0.15 to
0.05 by inducing long channel closings, similarly to those observed in the absence of CaM.
The open probability of the channel was decreased by SPC with an IC50 of 1.3± 0.3 μM and
0.7 ± 0.2 μM in the absence and presence of 100 nM CaM, respectively (Fig. 1C). Analysis
of single channel recordings showed that, both in the absence and presence of CaM, the
open and closed times of Ca2+-activated channels could be fitted by the sum of two
exponentials (data not shown), in agreement with a previous report [21]. SPC significantly
increased lifetimes of the second closed state (an increase from 3.21 ± 2.09 ms to 452 ± 140
ms and from 16.53 ± 6.21 ms to 619 ± 242 ms in the absence and presence of 100 nM CaM,
respectively, Table 1).
Micellar SPC affects [3H]ryanodine binding in a CaM-dependent and -independent manner
We have previously shown that clusters of SPC are required for an efficient interaction with
CaM, thus, to see an effect on the Ca2+ sensor, SPC has to be applied at concentrations near
its critical micelle concentration (CMC, ~30 μM) [17]. We could not study the effects of
micellar SPC in single channel measurements, because the sensitive lipid bilayer broke at
SPC concentrations above 10 μM. To explore the effect of SPC on RyR activity at
concentrations expected to disrupt the CaM-RyR interaction, [3H]ryanodine binding assays
were conducted. This ligand binding assay is a good indicator of channel activity, since the
plant alkaloid ryanodine has been shown to bind with higher affinity to the open than the
closed channel state [22].
Measurements with skeletal SR vesicles at 50 μM free Ca2+, under both reducing (5 mM
GSH) and oxidizing (5 mM GSSG) conditions were carried out. Ca2+ concentration was
optimized to saturate CaM, but not to inhibit RyR activity directly [15]. An oxidizing
environment is expected to yield higher ryanodine but lower CaM binding, while CaM is
expected to be inhibitory under both conditions [15].
In the absence of CaM, SPC inhibited [3H]ryanodine binding with an apparent IC50 of 26.1
± 0.8 μM (Fig. 2A) and 25.5 ± 4.0 μM (Fig. 2C) under reducing and oxidizing conditions,
respectively. These values are approximately 20-fold higher than the ones obtained in the
single channel measurements and may have been caused by the different SPC to membrane
lipid ratios in the two techniques. The effect of SPC was selective compared to structurally
similar lysophospholipid mediators such as lysophosphatidylcholine (LPC) and
lysophosphatidic acid (LPA), but a minor inhibitory effect could also be observed in case of
sphingosine-1-phosphate (S1P) (Figs. 2B and D).
In the presence of CaM, on the other hand, SPC did not significantly alter [3H]ryanodine
binding. A possible explanation for this finding is that SPC exerts two opposing effects on
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the Ca2+CaM-bound RyR. Displacement of inhibitory Ca2+CaM from RyR1 has an
activating effect, whereas direct interaction with RyR1 is inhibitory, negating the effects of
SPC. [35S]CaM binding studies (see below) and the fact that S1P (which does not interact
with CaM [17,18]) further decreased [3H]ryanodine binding in the presence of CaM (Fig.
2D), favour this explanation.
SPC displaces CaM from skeletal muscle SR vesicles
[35S]CaM binding assays revealed that SPC displaces Ca2+-saturated CaM from skeletal SR
vesicles enriched in RyR1 with an IC50 of 14.2 ± 0.8 μM (Fig. 3A). This value compares
well with the results of peptide binding assays (IC50 = 19.4 ± 1.4 μM) [18]. S1P and LPA
were ineffective, while LPC also decreased [35S]CaM binding to SR vesicles (Fig.s 3B).
This effect is probably an artefact, as LPC also decreased nonspecific binding, and it was
without action in peptide binding experiments [18].
SPC does not break the permeability barrier of SR vesicle preparations
To rule out the possibility that SPC’s action on SR vesicles is an artefact of membrane
permeabilization, we examined the sphingolipid’s effect on the permeability barrier of
preparations used in the study. SR vesicles were loaded with [14C]glucose, and release was
determined after dilution in an unlabeled medium. We found that neither 50 μM SPC, S1P,
LPC or LPA increased glucose permeability significantly, while 1% CHAPS detergent
released a large amount of stored glucose (Fig. 4). Thus, the lysophospholipids used in our
measurements do not disrupt the permeability barrier.
Discussion
The effects of the lipid mediator SPC on the RyRs have been previously studied. One group
of investigators reported an activation of these receptors by the sphingolipid [9,10], while
another one observed channel inhibition [11,12]. Neither group examined the role of CaM in
this process. Since we formerly showed that SPC is a potent inhibitor of CaM-dependent
enzymatic activities [17], and selectively dissociates the complex between CaM and the
CaM-binding domain of RyR1 at concentrations near its CMC (~30 μM) [18], we studied
the interaction between RyR1 and SPC, focusing on the role of CaM in modulating this
interaction. According to our initial hypothesis, we expected that SPC, by dissociating CaM
from the RyR1, would relieve negative feedback inhibition of Ca2+CaM on the channel. By
leading to channel opening, SPC would mobilize intracellular Ca2+ [6].
In this report, we show that SPC indeed displaces CaM from the intact channel (Fig. 3). The
functional consequences of CaM dissociation were explored in single channel measurements
and a ligand ([3H]ryanodine) binding assay. Single channel recordings on purified RyR1
(Fig. 1) revealed that SPC at concentrations well below its CMC decreases the open channel
probability of RyRs, and induces the appearance of long-lived closed states. These data are
in good agreement with former reports that low concentrations of SPC decrease the open
probability of the cardiac ryanodine receptor (RyR2), and RyR2 inhibition is characterized
by the appearance of long-lived closed channel states [11,12]. As expected, this inhibitory
effect was independent of CaM, since we previously demonstrated that CaM only binds
efficiently to the micellar form of SPC. We were unable to study the effects of SPC on
RyR1 above the lipid’s CMC in single channel measurements, because SPC concentrations
greater than 10 μM resulted in disruption of the sensitive reconstituted bilayer.
To overcome this limitation, [3H]ryanodine binding experiments were carried out (Fig. 2),
which confirmed inhibition of receptor activity in the absence of CaM. However, if
Ca2+CaM was present, inhibition could not be observed. This phenomenon could be
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explained by assuming that two antagonistic molecular events are occurring at the same
time: 1) a direct inhibition of channel activity by the sphingolipid, as suggested by single
channel recordings and 2) displacement of inhibitory Ca2+CaM by SPC, as suggested by
[35S]CaM binding assays.
Taken together, our data are consistent with the findings of Uehara et al. [11,12] in that SPC
directly inhibits RyRs. Our current results are also consistent with our former data
suggesting that SPC can dissociate the complex between RyRs and CaM, and we have found
that the presence of CaM can modify the direct inhibitory effect of SPC on the channel. On
the other hand, an involvement of RyRs in SPC-induced Ca2+ release from brain
microsomes has been reported [9]. Hence, we studied RyR activity similarly as these authors
had, isolating microsomes from bovine brain cerebrum by differential centrifugation,
loading these with Ca2+ in presence of an ATP-regenerating system, and measuring Ca2+
release using a fluorescent Ca2+ indicator. We found that while 50 μM SPC, LPC and LPA
each released a large amount of Ca2+ from brain microsomes, classical channel activators
such as 1 μM ryanodine and 5 mM caffeine only had minor effects (data not shown).
Surprisingly, Dettbarn et al. [9] were also incapable of triggering Ca2+ release by ryanodine
or caffeine. Their major argument for SPC’s action on RyRs was that ruthenium red, an
inhibitor of the RyRs, inhibited SPC-induced Ca2+ release. However, in two subsequent
studies [10,23], SPC-induced Ca2+ release was much less sensitive to ruthenium red
inhibition. Taken together, the sphingolipid’s mechanism of action on cerebral microsomes
remains elusive, but a significant contribution of RyRs to the phenomenon can most likely
be excluded.
In conclusion, we have shown that SPC regulates RyR1 in a diverse manner. Below the
CMC, SPC directly inhibits the skeletal muscle Ca2+ release channel, while above the CMC,
besides a direct action on the channel, the sphingolipid also displaces inhibitory Ca2+CaM
from the RyR1, further modifying channel activity. Here we note that we use micelles as the
simplest alternative for the in vitro presentation of an SPC cluster to CaM, which might arise
in vivo upon the activation of an SPC producing enzyme. Net activation of the channel never
occurs, so SPC’s effect on the RyR cannot explain how the sphingolipid liberates Ca2+ from
the endoplasmic reticulum. Although this question remains open, we have clarified the role
of SPC in RyR regulation. The relevance of the findings in the present study regarding the in
vivo role of SPC in regulating the skeletal muscle RyR and the receptor’s interaction with
CaM remains to be shown, but it is tempting to speculate that the sphingolipid might locally
modify channel function in living cells.
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Effects of SPC on single channel activities of purified RyR1 in absence and presence of 100
nM CaM. (A) Single channel currents were recorded at +35 mV before (top 3 traces) and
after the addition of 1 μM SPC cis (bottom 3 traces) in symmetrical 0.25 M KCl in presence
of 22 μM free Ca2+ cis and absence of CaM. The closed states are indicated by c--. (B) As in
(A) in presence of 100 nM CaM. Proteoliposomes were incubated with 1 μM CaM for 30
min before the addition to the cis chamber of the lipid bilayer system, and channels were
recorded in presence of 100 nM CaM in the cis chamber. (C) Dependence of purified RyR1
channel activity on SPC concentration in absence and presence of CaM. Relative open
channel probability (Po/Po,control) was obtained from single channel recordings similar to
those shown in panels A and B. Solid lines were obtained according to the equation Po =
Po,control (1 + [SPC]/Ki)− 1, where Ki is the inhibition constant and Po and Po,control are
single channel open probabilities in presence and absence of SPC. Inhibition constants in the
absence (n=6) and presence (n=10) of 100 nM CaM were 1.3 ± 0.3 μM and 0.7 ± 0.2 μM,
respectively.
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Effect of SPC on [3H]ryanodine binding to skeletal SR vesicles. Free Ca2+ concentration
was set to 50 μM and either 5 mM GSH (A,B) or 5 mM GSSG (C,D) was added. Open
circles and light bars depict [3H]ryanodine binding in the absence of CaM, while closed
circles and dark bars depict [3H]ryanodine binding in the presence of 0.1 μM (A,B) and 1
μM (C,D) CaM. In the absence of CaM, the dose-response for SPC yielded an apparent IC50
of 26.1 ± 0.8 μM and 25.5 ± 4.0 μM and a Hill-slope of −1.7 ± 0.04 and −2.9 ± 0.2 under
reducing (A) and oxidizing (C) conditions, respectively. Data points depict mean ± S.E.
(n=3), a sigmoidal dose-response curve with variable slope was fitted to the data, and
asterisks denote significant differences at p<0.05 compared to control.
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Displacement of [35S]CaM from RyR1 by SPC. (A) SPC dissociates Ca2+-saturated
[35S]CaM from skeletal SR vesicles rich in RyR1 with an IC50 of 14.2 ± 0.8 μM and a Hill-
slope of 2.3 ± 0.7. Data points depict mean ± S.E. (n=3), a sigmoidal dose-response curve
with variable slope was fitted to the data. (B) Among the tested lysophospholipids, SPC and
LPC significantly decrease [35S]CaM binding to skeletal SR vesicles. Data points depict
mean ± S.E. (n=3), asterisks denote significant differences at p<0.05 compared to control.
Note that the effect of LPC is probably an artefact as LPC also decreased nonspecific
binding, and it was without action in peptide binding assays [18].
Kovacs et al. Page 11














Effect of SPC on the membrane permeability of skeletal SR vesicle preparations. Vesicles
were loaded with [14C]glucose and retained radioactivity was measured after dilution into
unlabeled release medium.
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Table 1
Effect of SPC on purified RyR1 channel parameters in the absence and presence of CaM. Channel parameters
were obtained from 2 min continuous recordings as described in Experimental Procedures. Po refers to open
channel probability. Dwell-time data were fitted by the maximum likelihood method to the probability density
function: f(t) = ΣAi (1/τi) exp (−t/τi), where Ai and τi are the relative areas of the distributions and time
constants of the ith state, respectively [24]. Both the open and closed time histograms could be fitted by the
sum of two exponentials.
Channel parameter
Additions to cis bilayer chamber
22 μM Ca2+ 22 μM Ca2+ and 100 nM CaM
−1 μM SPC +1 μM SPC −1 μM SPC +1 μM SPC
No. of events 19,874 ± 7337 9767 ± 1884 20,544 ± 4074 10,392 ±2633*
Po 0.52 ± 0.16 0.24 ± 0.10 0.39 ± 0.12 0.18 ± 0.09*
Ao1 0.87 ± 0.12 0.81 ± 0.18 0.91 ± 0.08 0.94 ± 0.05
Ao2 0.13 ± 0.12 0.19 ± 0.18 0.09 ± 0.08 0.06 ± 0.05
τo1 (ms) 0.56 ± 0.53 0.24 ± 0.19 0.26 ± 0.22 0.16 ± 0.12
τo2 (ms) 2.93 ± 2.22 5.09 ± 3.32 1.48 ± 0.85 3.12 ± 2.10
Ac1 0.98 ± 0.01 0.994 ± 0.003 0.85 ± 0.09 0.96 ±0.03
Ac2 0.02 ± 0.01 0.006 ± 0.003 0.15 ± 0.09 0.04 ± 0.03
τc1 (ms) 0.05 ± 0.02 1.07 ± 0.68 0.77 ± 0.47 2.81 ± 1.66
τc2 (ms) 3.21 ± 2.09 452 ± 140* 16.53 ± 6.21 619 ± 242*
*
Values significantly different from the − SPC control (P < 0.05; n = 4 and 6 in case of −CaM and +CaM samples, respectively).
1
Sphingosylphosphorylcholine (SPC) directly inhibits ryanodine receptor 1 (RyR1).
2
SPC also displaces calmodulin (CaM) from the intact RyR1.
3
The sphingolipids effect on RyR1 is further modified by the removal of CaM.
4
Thus, SPC regulates channel activity in both a CaM-dependent and -independent manner.
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